...
首页> 外文期刊>Analytical Biochemistry: An International Journal of Analytical and Preparative Methods >A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimeraptamer as donor-acceptor pair
【24h】

A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimeraptamer as donor-acceptor pair

机译:使用抗体官能化发光碳点和AUNPS-DENDRIMERAPTAMER作为供体 - 受体对的人血清样品和乳腺癌细胞中CA 15-3肿瘤标志物敏感检测的荧光免疫传感器

获取原文
获取原文并翻译 | 示例
           

摘要

We proposed a FRET immunosensing for detection of CA15-3 tumor marker by highly biospecific interactions between CA 15-3 antigen and the corresponding antibody and aptamer. In this sandwich type immunoassay, CA15-3 antibody-functionalized carbon dots and AuNPs labeled PAMAM-Dendrimer/aptamer were used as donor/acceptor, respectively. When CA 15-3 Ag was added to homogenous immunoassay, the strong complex interaction between CA15-3 Ab-CA15-3 Ag- aptamer caused in more coming closer carbon dot and AuNPs and more decreasing fluorescence signal. The decreased fluorescence intensity was linear at three ranges including in concentration range 1.1 mu UmL(-1) to 16 mu U mL(-1) with regression of R-2 = 0.9879, at the concentration range 16 mu U mL(-1) to 0.163 mU mL(-1) with regression of R-2 = 0.9944 and at the concentration range 0.163 mU mL(-1) to 5.0 mU mL(-1) with regression of R-2 = 0.9805. The detection limit of the FRET immunoassay was 0.9 mu U mL(-1). This assay revealed good sensitivity and specificity with MDA-MB-231 breast cancer cells concentrations from 1000 to 40000 cells/mL with correlation coefficient of 0.9955 and detection limit of 300 cells/mL (3 cells in 10 mu L of injected sample). In addition, this FRET immunosensing is applicable in diluted human serum. The recovery values were in the range of 95.86-96.97% for CA 15-3 Ag in spiked serum sample with RSD lower than 7.3%. The proposed immunoassay could be a valid model for establishing other immunoassays for detection of different cancer tumor markers with relevant antigens and antibodies.
机译:我们提出了一种通过Ca 15-3抗原和相应抗体和适体的高度生物特异性相互作用来检测Ca15-3肿瘤标志物的FRET免疫溶解。在这种夹层型免疫测定中,Ca15-3抗体官能化的碳点和标有PAMAM-树形树枝状聚合物/适体的AUNPS分别用作供体/受体。当加入到均匀的免疫测定中时,Ca15-3 Ab-Ca15-3之间的强复合物相互作用在更接近的碳点和肛门孔中引起,荧光信号更加降低。荧光强度下降在三个范围内,包括浓度范围1.1μmmm(-1)至16μuml(-1),在浓度范围内的R-2 = 0.9879的回归(-1) 0.163μml(-1),R-2 = 0.9944的回归,浓度范围为0.163μml(-1)至5.0μml(-1),R-2 = 0.9805的回归。 FRET免疫测定的检测极限为0.9μmuml(-1)。该测定揭示了MDA-MB-231乳腺癌细胞浓度为1000至40000个细胞/ mL的良好敏感性和特异性,其相关系数为0.9955,检测限为300个细胞/ ml(10μL注入样品中的3个细胞)。此外,这种荧光免疫溶胶适用于稀释的人血清。掺入血清样品中的Ca 15-3 Ag的回收值在95.86-96.97%的范围内,RSD低于7.3%。所提出的免疫测定可以是建立其他免疫测定的有效模型,用于检测具有相关抗原和抗体的不同癌症肿瘤标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号